Calcutt et al., Gene, 137(1):77-83 (1993). |
Pesce et al., Nucleic Acid Research, 22(4): 656-661 (1994). |
Markovitz et al., Analytical Biochemistry, 94:259-264 (1970). |
Rye et al, Nucleic Acid Research, 20:2803-2812 (1992). |
Airas, Biochemistry, 33:7193 (1994). |
Friguet et al., Protein Structure: A Practical Approach, Creighton, Ed., IRL Press (Oxford 1989). |
Volkins et al., Proceedings of the Ninth International Biotechnology Symposium and Exposition, American Chemical Society, 1992, cover pages and pp. 299-302. |
Fercht, Curr. Opinion in Struc. Biol. 7:3 (1997). |
Schellman, Biopolymers, 15:999-1000 (1976). |
Tanigaki, Nobuyuki (Citation Unknown) pp. 577-690 (1993). |
Weber et al., J. Am. Chem. Soc., 16:2716 (1994). |
Burke et al., Biochemistry, 32:6419-6426 (1993). |
Volkin et al., Archives of Biochemistry and Biophysics, 300:31-41 (1993). |
Hu et al., Biochemistry, 31:4876-82 (1991). |
Copeland et al., Archives of Biochemistry and Biophysics, 289:53-61 (1991). |
Dabora et al., J. Biol. Chem., 266:23637-40 (1991). |
Pace, TIBS 15, Jan. 1990, 14-17. |
Keating et al., Biochemistry, 27:5240-5 (1988). |
Permyakov et al., Biophys. Chem., 32:37-42 (1988). |
Allen and Wong, Arch. Biochim. Biophys., 249:137-147 (1986). |
Busby and Ingham, Biochem. Biophys. Acta, 871:61-71 (1986). |
Pace and Creighton, J. Mol. Biol., 188:477-486 (1986). |
Schnarr and Maurizot, Biochim. Biophys. Acta, 871:61-71 (1986). |
Klesov and Gerasimas, Biokhimiia, 44:1084-92 (1979). |
Oobatake et al., J. Biochem., 86:65-70 (1979). |
Blazyk and Lam, Biochemistry, 15:2843-8 (1976). |
Doyle et al., Carbohydr. Res., 46:111-8 (1976). |
DeFlora et al., Ital. J. Biochem., 24:147-61 (1975). |
Takahasi, J. Biochim., 75:201-204 (1974). |
Ranall, Science, 257:241-245 (1922). |
Brandts et al., Biochemistry, 29:6927 (1990). |
Parsell and Sauer, J. Biol. Chem., 264:7590-7595 (1989). |
Pace and McGrath, J. Biol. Chem., 255:3862-3865 (1980). |
Green et al., J. Biol. Chem., 266:21472 (1991). |
Wagenhofer et al., Anal. Biochem., 175:422-432 (1988). |
Cass-Finet et al., J. Mol. Biol., 229:873-889 (1988). |
Kuwajima et al., Int. J. Peptide Protein Res., 27:18-27 (1986). |
Lapadat and Spremulli, J. Biol. Chem., 24:5510-5514 (1989). |
Feng and Sligar, Biochemistry, 35:10150-10155 (1991). |
Tanigaki et al., Human Immunology, 36:119-127 (1993). |
Rosengart et al., Biochem. Biophys. Res. Commun., 152:432-440 (1988). |
Chavan et al., Biochemistry, 33:7193 (1994). |
Airas, Biochem. Biophys. Acta, 425:193-200 (1976). |
Wang, J. Biol. Chem., 268:20785-20790 (1993). |
Grimaldi et al., Biochemistry, 21:145-151 (1982). |
Zahnley. J. Inorganic Biochem., 15:67-78 (1976). |
Doyle et al., Carbohydrate Res., 46:111-118 (1976). |
Feng and Slinger, Biochemistry, 30:10150-10155 (1991). |
Kahn, Biochemistry, 31:8829-8834 (1992). |
Fernandez-Ballester et al., Biochem. J., 228:421-426 (1992). |
Expert Report of James R. Broach on Issue of Patent Invalidity, Scriptgen Pharmaceuticals v. 3-Dimentional Pharmaceuticals, U.S. District Court, Delaware, Jan. 7, 2000. |
Opening Brief in Support of Defendant's Motion for Summary Judgment on Invalidity, Scriptgen pharmaceuticals v. 3-Dimentional pharmaceuticals, U.S. District Court, Delaware, Jan. 7, 2000. |
Scriptgen Pharmaceuticals, Inc.'s Answering Brief on Opposition to Defendant's Motion for Summary Judgment of Invalidity, Scriptgen Pharmaceuticals v. 3-Dimentional Pharmaceuticals, U.S. District Court, Delaware, Feb. 1, 2000. |
Defendant's Reply Brief in Support of Defendant's Motion for Summary Judgment of Invalidity, Scriptgen Pharmaceuticals v. 3-Dimentional Pharmaceuticals, U.S. District Court, Delaware, Feb. 28, 2000. |
Bowie, Identifying Determinants of Folding and Activity for a Protein of Unknown Structure, B.A., Chemistry, Carleton College (1981), Submitted to the Department of Biology if Partial Fulfillment of the Requirements fo the Degree of Doctor of Philosophy at the Massachusetts Institute of Technology, May 1989. |
Enna, “Radioligand Binding Assays”, Principals and Methods in Receptor Binding, pp. 13-33, Plenum Publishing Corp. (1987). |
Fuller and Steranka, “Drug Discovery at the Enzyme level”, Drug Discovery and Development, pp. 177-198, Humana Press (1987). |
Enna, “Biochemical Approaches for Evaluating Drug-Receptor Interactions”, Drug Discovery and Development, pp. 151-176, Humana Press (1987). |
Baldwin, “Drug Design”, Drug Discovery and Development, pp. 33-71, Humana Press (1987). |
Williams and Malick, “Drug Discovery and Development”, Drug Discovery and Development, pp. 3-29 (1987). |
Kinner, “Receptor Binding as a Method for Drug Discovery”, Drug Discovery and Development, Humana Press (1987). |
Beith et al., Biochemical Medicine, 11:350-357 (1974). |
Gething and Sambrook, Nature, 355:33-45 (1992). |
Hardy and Randall, Science, 251:439-443 (1991). |
Crotheres, D.M., Draft Opinion, Scriptgen Pharmaceuticals v. 3-Dimentional Pharmaceuticals, U.S. District Court, Delaware, pp. 1-15, Oct. 20, 1999. |
Horwitz et al., Memorandum Opinion, Scriptgen Pharamceuticals v. 3-Dimentinal Pharmaceuticals, U.S. District Court, Delaware, Dec. 15, 1999. |
Chen et al., Anal Chem. 64:3018-3023 (1992). |
Silverman et al., Current Opinion in Chemical and Biochemistry, 397-403 (1998). |
Volkin et al., “The Effect of Polyanions on the Stabilization of Acidic Fibroblast Growth Factor”, Harnessing Biotechnology for the 22st Century, 9th Int'l Biotechnology Symposium, American Chemical Society, pp. 298-302 Aug. 1992. |
Pakula, “A genetic and Biological Analysis of the Bacteriophage .lamda. Cro Protein ”, B.S., Biol. And Chem., Tufts Univ. (1980), Submitted to the Department of Biology in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy at Massachusetts Institute of Technology, Sep. 1988. |
Pantolliano, M.W., Senior Director, Biophysical Chemistry, 3-Dimentional Pharmaceuticals, Inc., “The ThermoFlou.RTM. Strategy for High-Throughput Screening of Chemical Libraries Against Therapeutic Targets Including Those Derived from Genomics”, pp. 1-17 (1999). |
Alderman, E.M., Director, Pharmaceutical Research, New Ventures, Zymark Corporation, “Abbreviating the Assay Development Process Through Sealable Automation Tehcnology” (1999). |
Wainer, I.W., Professor of Pharmacology, Georgetown University of Medical Center, Immobilized Receptor-Based Liquid Chromotographic Stationary Phases for Rapid On-Line Screening (1999). |
Little, J.N., Senior Vice President, Cetec Corporation, “A Powerful New Screening Technology Utilizing Capillary Electrophoresis” (1997). |
Yeh, Li-An, Director, Drug Discovery, NEN Life Science Products, Development of a Novel Phospholipase C Assay in HTS: A Functional Assay for GPCR (1997). |
Zhang et al., Analytical Biochemistry, 264:22-25 (1988). |
Scott and Smith Science, 249:386-390 (1997). |
Schellman, Biophysical Chemistry, 45:273-279 (1993). |
Ferst, Current Opinion in Structural Biology, 7:3-9 (1997). |
Brandts et al., American Laboratory, 22:30-4 (1990). |
Brandts et al., Biochemistry, 29:6927-6940 (1990). |
Barcelo et al., Chem. Biol. Interactions, 74:315-324 (1990). |
Schellman, Biopolymers, 14:999-1019 (1975). |
Weber et al., J. Am. Chem. Soc., 116:1717-1724 (1994). |
Bouvier and Wiley, Science, 265:398-402 (1994). |
Morton et al., Biochemistry, 34:8564-8575 (1995). |
Volkin et al., Biochemistry, 34:8564-8575 (1995). |
Pakula, Annu. Rev. Genet. 23:289-310 (1989). |
Moos et al., Chapter 33, Annual Reports in Medicinal Chemistry (1993). |
Gordon et al., Journal of Medicinal Chemistry, Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions, vol. 3, No. 10 (1994). |
Gallop et al., Journal of Medicinal Chemistry, Applications of Combinatorial Technologis to Drug Discovery. 1. Background and Peptide Combinatorial Libraries, vol. 37, No. 9 (1994). |
Devlin, Science, vol. 245 (1990). |
Pace and Grimsley, Ribonuclease T.sub.1 is Stabilized by Cation and Anion Binding, American Chemical Society (1998). |
Weber et al., Journal of American Chemical Society, vol. 116 (1994). |
Walz, et al., The Journal of biological Chemistry, (1990). |
Lam et al., Nature, vol. 354 (1991). |
Pace, Archives of Biochemistry and Biophysics, 199:270-276 (1980). |
Tsai et al., Pharmaceutical Research, vol. 10, No. 5 (1993). |
Morton et al., Biochemistry, 34:8513 (1995). |
Erikson et al., Nature, 335:371 (1992). |
Derwent Publications. Abstract No. 75-43214W (1992). |
Eftink, Biophys. J., 66:482-501 (1994). |
Grant et al., Biochemistry, 31:9491-9501 (1992). |
Lee et al., FEBS Letters, 339:165-167 (1994). |
Harrington, Int. J. Biochem. 24:275-280 (1992). |
Davidson et al., Proc. Natl. Acad. Sci. USA, 91:2146-2150 (1994). |
Scott et al., Science, 249:386 (1990). |
Weber et al., J. Am. Chem. Soc., 16: 2717 (1994). |
Schellman, Biophysical Chem., 45:273 (1993). |
Barcelo et al., Chem. Biol. Interactions, 74:315 (1990). |
Nilsson et al., Annu. Rev. Microbiol., 45:607-635 (1991). |
Merabet et al., Biochim. Biophys. Acta, 1161:272-278 (1993). |
Baumann et al., Eur. J. Biochem., 170:267-272 (1987). |
Draper et al., Meth. Enzymol., 259:281-305 (1995). |
Gassen, Prog. Nuc. Acid Res. And Molec. Bio., 24:57-83 (1980). |
Stanford et al., Nuc. Acid Res., 16:10643-10655 (1988). |
Zapp et al., Anal. Biochem., 74:969-978 (1993). |
Matthews et al., Anal. Biochem., 169:1-25 (1988). |
Totsuka et al., BBRC, 208(I):168-173 (Mar. 8, 1995). |
Kutyavin et al., Biochemistry, 35:1170-1176 (1996). |
Woo et al., Nuc. Acid Res., 24:2470-2475 (1996). |
Wang et al., Biochemistry, 35:12338-12346 (1996). |
Wang et al., Biochemistry, 36:768-779 (1997). |
Schwille et al., Biochemistry, 35:10182-10195 (1996). |
Green et al., J. Mol. Biol., 235:237-246 (1994). |
Lacowicz, Principles of Fluorescence Spectroscopy, pp. 111-115, Plenum Press (1983). |
Introduction to Fluorescence Polarization, Fluorescence Polarization Hand Book: Methods in Fluorescence Polarization, Pan Vera Corp., Madison, WI (608)233-5050 (1996). |